Taken together, these findings suggest that miR-331-3p acts as a tumor suppressor in the brain by coordinately inhibiting expression of multiple target molecules, including NRP-2 and DOHH, leading to reduced GBM cell proliferation and clonogenic growth. The gene discussed is NRP2; the disease is glioblastoma.